Albertsons

Q1 FY2027 EarningsQ1 FY26 results slightly exceeded revenue consensus at $24.94B (+0.36% variance), but significantly missed bottom-line expectations with normalized EPS of $0.42 vs. $0.54 expected (-22.00% variance). The miss was driven by a gross margin contraction to 26.6% (vs. 27.05% expected) and elevated selling and administrative expenses (25.6% of sales) resulting from merger-related litigation and business transformation costs. While digital sales grew 13%, identical sales (ex-fuel) declined 0.8%, reflecting a pressured consumer environment and pharmacy headwinds.